PG
REGN icon

PEAK6 Group’s Regeneron Pharmaceuticals REGN Stock Holding History

PEAK6 Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$6.52M Sell
18,900
-32,500
-63% -$10.2M 0.03% 646
2018
Q1 		$17.7M Buy
51,400
+5,300
+11% +$1.84M 0.08% 260
2017
Q4 		$17.3M Sell
46,100
-41,800
-48% -$16.9M 0.08% 273
2017
Q3 		$39.3M Buy
87,900
+19,100
+28% +$9.09M 0.2% 76
2017
Q2 		$33.8M Buy
68,800
+8,000
+13% +$3.5M 0.2% 83
2017
Q1 		$23.6M Buy
60,800
+33,000
+119% +$12.2M 0.19% 90
2016
Q4 		$10.2M Sell
27,800
-13,700
-33% -$5.21M 0.07% 353
2016
Q3 		$16.7M Sell
41,500
-6,000
-13% -$2.41M 0.12% 172
2016
Q2 		$16.6M Buy
47,500
+13,200
+38% +$5.08M 0.13% 162
2016
Q1 		$12.4M Sell
34,300
-63,000
-65% -$26M 0.1% 249
2015
Q4 		$52.8M Sell
97,300
-102,800
-51% -$55.7M 0.36% 18
2015
Q3 		$93.1M Buy
200,100
+135,300
+209% +$72.7M 0.49% 7
2015
Q2 		$33.1M Sell
64,800
-28,500
-31% -$13.9M 0.2% 75
2015
Q1 		$42.1M Sell
93,300
-112,700
-55% -$47.8M 0.32% 23
2014
Q4 		$84.5M Buy
206,000
+70,800
+52% +$27.8M 0.64% 3
2014
Q3 		$48.7M Buy
135,200
+22,200
+20% +$7.44M 0.38% 21
2014
Q2 		$31.9M Buy
113,000
+14,200
+14% +$4.21M 0.3% 31
2014
Q1 		$29.7M Buy
98,800
+64,700
+190% +$19.9M 0.25% 39
2013
Q4 		$9.39M Sell
34,100
-32,900
-49% -$9.46M 0.07% 355
2013
Q3 		$10.5M Buy
67,000
+60,000
+857% +$15.8M 0.07% 312
2013
Q2 		$1.57K Buy
+7,000
New +$1.63M 0.01% 1751

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PEAK6 Group's REGN Position: Q2 2018 in Review

PEAK6 Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 4,713 shares — an estimated $1.47M sold.

PEAK6 Group first reported a position in REGN in Q3 2013 and held it in 13 quarters. The position peaked at $27.6M in Q3 2015. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

  • PEAK6 Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 4,713 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $1.47M.
  • PEAK6 Group first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 13 quarters.
  • PEAK6 Group's Regeneron Pharmaceuticals position peaked at $27.6M in Q3 2015.
  • 624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.